Eric Verdin

President and CEO, Buck Institute for Research on Aging

Belgian geroscientist who has led the Buck Institute for Research on Aging since 2016 and is a professor of medicine at UCSF. His research covers how metabolism, diet and small molecules such as NAD+ and the ketone body beta-hydroxybutyrate regulate sirtuins, HDACs and aging. His lab also studies how nutrition affects the immune system and the chronic inflammation linked to diseases of aging.

WHAT TO WATCHThe Buck Institute's first human clinical trial, the Buck Institute Ketone Ester (BIKE) study announced in 2023, and his lab's work on nutrition, metabolites and inflammation in aging.